Davide Lazzarotto
13PUBLICATIONS
38CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (13)
Sort by Publication Date:
|Aug 26, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.Davide Lazzarotto, Anna Maria Testi, Matteo Fanin
|Aug 11, 2025
Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti
|Feb 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi
|Jun 19, 2024
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.Anna Candoni, Patrizia Chiusolo, Davide Lazzarotto
|Sep 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.Nicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis
Pageof 3
Frequent Collaborators
6 joint publications
Anna Candoni
3 joint publications
Fabio Forghieri
3 joint publications
Maria Ilaria Del Principe
3 joint publications
Marco Cerrano
2 joint publications
Felicetto Ferrara
2 joint publications
Mario Delia
2 joint publications
Massimiliano Bonifacio
2 joint publications
Patrizia Zappasodi
2 joint publications
Elisa Buzzatti
2 joint publications
Mariarita Sciumè